Innovative Research, Inc. Acquires Molecular Innovations, Inc.

Posted by Adam Awdish on

Novi, MI, October 1, 2021 - Innovative Research, Inc. has finalized its agreement to acquire Molecular Innovations, Inc.  “These two companies have been strategic partners for the past twenty years, it only makes sense they merge and improve future collaboration and operations,” says Carl Rosenblum, Director of Customer Support at Innovative Research.  “As we went through this process it became clearer what we were gaining as a total organization by joining Innovative Research,” said Duane Day, President and Owner of Molecular Innovations, Inc.


This combination of resources will allow Innovative Research to leverage the thirty years of high-quality production and expertise in coagulation and thrombolysis while identifying new areas of product development and investment to meet customer need. Headquarters will be maintained in Novi, MI and Innovative Research will continue to provide reliable reagents to clients both domestic and International.

If you have an unfulfilled Molecular Innovations Sales Order, you will be notified with updated information on October 4, 2021. Should your original PO need revised for proper fulfillment, your assistance in doing so is appreciated.  Please direct any inquiries to Carl Rosenblum, 248-896-0145, ext. 102.


Share this post


Related Posts

Innovative Research Forms Strategic Partnership with Bioz
Innovative Research is pleased to announce a strategic partnership with Bioz, Inc., a l...
Read the Article
GLP-1 Drugs: A Paradigm Shift in Obesity Treatment
We have entered a new era in the world of obesity treatment, with a clear and distinct ...
Read the Article
5 End-of-Year Promotions You Don’t Want to Miss from Innovative Research
As the year 2023 ends, we at Innovative Research want to thank you for your continued s...
Read the Article

← Older Post Newer Post →

×